The mean of analysts' price targets for Kiniksa Pharmaceuticals International, plc (KNSA) points to a 36% upside in the stock. While this highly sought-after metric has not proven reasonably effective ...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.16 EPS, expectations were $0 ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual ...

Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.